KEGG   DRUG: Defibrotide sodiumHelp
Entry
D07423                      Drug                                   

Name
Defibrotide sodium (JAN/USAN);
Defitelio (TN)
Product
Remark
Therapeutic category: 3919
ATC code: B01AX01
Product: D07423<JP/US>
Efficacy
Antithrombotic, Thrombogenesis factor regulator
Comment
Polydeoxyribonucleotides from bovine lung or other mammalian organs with molecular weight between 15,000 and 30,000.
Treatment of hepatic veno-occlusive disease
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AX Other antithrombotic agents
     B01AX01 Defibrotide
      D07423  Defibrotide sodium (JAN/USAN) <US>
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   391  Liver disease agents
    3919  Others
     D07423  Defibrotide sodium (JAN/USAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D07423
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D07423
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D07423
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D07423
BRITE hierarchy
Other DBs
CAS: 83712-60-1
PubChem: 51091757
DrugBank: DB04932
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system